Sarcoidosis Restrictive Spirometry with Reduced DLCO
medium
stethoscope Medicine
A 42-year-old woman presents with progressive dyspnea and cough. Chest X-ray shows bilateral hilar lymphadenopathy with parenchymal infiltrates. Spirometry reveals the pattern marked **A** in the diagram—reduced FVC with preserved FEV1/FVC ratio. High-resolution CT confirms interstitial infiltrates consistent with sarcoidosis. Which of the following findings would BEST support the diagnosis of pulmonary sarcoidosis in this patient?
A. Normal diffusing capacity for carbon monoxide (DLCO) with preserved alveolar-capillary membrane integrity
B. Obstructive airway physiology with reduced FEV1/FVC ratio and endobronchial involvement
C. Demonstration of non-caseating epithelioid granulomas on transbronchial biopsy with exclusion of tuberculosis and fungal infection
D. Presence of caseating granulomas on lung biopsy with positive acid-fast bacilli staining
Explanation
Why "Demonstration of non-caseating epithelioid granulomas on transbronchial biopsy with exclusion of tuberculosis and fungal infection" is right
The diagnosis of sarcoidosis requires three components: (1) compatible clinical-radiographic picture (bilateral hilar lymphadenopathy ± parenchymal infiltrates), (2) histologic demonstration of NON-CASEATING GRANULOMAS, and (3) exclusion of mimics such as tuberculosis, fungal infection, berylliosis, and lymphoma (ATS/ERS/WASOG 2020). The restrictive spirometric pattern marked A—reduced FVC with preserved FEV1/FVC ratio—emerges as parenchymal involvement progresses (Scadding Stage II–IV), reflecting interstitial lung disease. Transbronchial biopsy demonstrating non-caseating granulomas with negative TB and fungal cultures/stains fulfills the diagnostic gold standard.
Why each distractor is wrong
Obstructive airway physiology with reduced FEV1/FVC ratio and endobronchial involvement: This describes an obstructive pattern (marked D in the diagram), not the restrictive pattern A. While 10–20% of sarcoidosis patients develop obstructive physiology from endobronchial granulomas, the patient's spirometry shows preserved FEV1/FVC (restrictive), not reduced FEV1/FVC (obstructive).
Normal diffusing capacity for carbon monoxide (DLCO) with preserved alveolar-capillary membrane integrity: DLCO is the most sensitive marker of interstitial involvement in sarcoidosis and is REDUCED out of proportion to lung volumes due to alveolar-capillary membrane thickening and granulomatous destruction. A normal DLCO would argue against significant parenchymal sarcoidosis and would be inconsistent with the clinical presentation.
Presence of caseating granulomas on lung biopsy with positive acid-fast bacilli staining: Caseating granulomas with positive AFB staining are pathognomonic for tuberculosis, not sarcoidosis. Sarcoidosis is defined by NON-CASEATING granulomas. This finding would exclude sarcoidosis and point toward TB.
